ArticleAmerican journal of blood research2021

Human leukocyte antigen (HLA) alleles as predictive factors for benefit from lenalidomide in acute myeloid leukemia (AML).

Sachin Punatar et al.PubMed ↗Full text ↗

No numbers read from the abstract.